CYCLERION THERAPEUTICS, INC.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$10M
↑+4.3% +$410Kvs FY2024
Total Liabilities
$900K
↑+24.1% +$175Kvs FY2024
Equity
$9M
↑+2.7% +$235Kvs FY2024
Cash
$3M
↑+0.2% +$8Kvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $10M | $10M |
| Current Assets | $5M | $4M |
| Cash | $3M | $3M |
| ST Investments | $0 | $0 |
| Receivables | $1M | $556K |
| Inventory | $0 | $0 |
| Other Current | $395K | $437K |
| Non-Current Assets | $5M | $5M |
| PPE | $0 | $0 |
| Goodwill | $0 | $0 |
| Intangibles | $0 | $0 |
| Investments | $0 | $0 |
| Other Non-Current | $5M | $5M |
| Total Liab+Eq | $9M | $9M |
| Current Liab. | $900K | $725K |
| Accounts Payable | $508K | $390K |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $0 |
| Other CL | $392K | $335K |
| Non-Current Liab. | $0 | $0 |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $0 | $0 |
| Equity | $9M | $9M |
| Retained Earnings | $271M | $267M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · CYCN · Comparing FY2025 vs FY2024